Dynamic Technology Lab’s Royalty Pharma RPRX Stock Holding History

Dynamic Technology Lab’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-11,955	Closed	-$315K	–	1306
2024 Q2	$315K	Sell	11,955 -15,768	-57%	-$437K	0.04%	667
2024 Q1	$842K	Buy	27,723 +7,007	+34%	+$207K	0.09%	393
2023 Q4	$582K	Buy	+20,716	New	+$569K	0.06%	538
2023 Q3	–	Sell	-55,471	Closed	-$1.71M	–	1270
2023 Q2	$1.71M	Buy	55,471 +37,098	+202%	+$1.26M	0.22%	130
2023 Q1	$662K	Buy	18,373 +413	+2%	+$15.3K	0.06%	526
2022 Q4	$709K	Sell	17,960 -3,920	-18%	-$164K	0.07%	457
2022 Q3	$879K	Buy	+21,880	New	+$935K	0.09%	422
2022 Q2	–	Sell	-10,760	Closed	-$420K	–	1481
2022 Q1	$420K	Buy	+10,760	New	+$423K	0.05%	654
2021 Q3	–	Sell	-6,668	Closed	-$273K	–	1418
2021 Q2	$273K	Buy	+6,668	New	+$284K	0.03%	824

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dynamic Technology Lab's RPRX Position: Q3 2024 in Review

Dynamic Technology Lab sold out of Royalty Pharma (RPRX) in Q3 2024, closing a stake of 11,955 shares — an estimated $315K sold.

Dynamic Technology Lab first reported a position in RPRX in Q2 2021 and held it in 9 quarters. The position peaked at $1.71M in Q2 2023. 395 funds tracked by Wall St. Rank hold RPRX as of Q3 2024.

Dynamic Technology Lab reported no remaining Royalty Pharma position as of Q3 2024 after selling out during the quarter.
Dynamic Technology Lab sold 11,955 Royalty Pharma shares in Q3 2024, an estimated $315K.
Dynamic Technology Lab first reported a position in Royalty Pharma in Q2 2021 and held it in 9 quarters.
Dynamic Technology Lab's Royalty Pharma position peaked at $1.71M in Q2 2023.
395 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2024.

Based on Dynamic Technology Lab's 13F filing for Q3 2024, filed 13 Nov 2024.